flucop.eu valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: | ||
Meta Tags
| Title | FLUCOP – Standardisation and development of assays for assessment of influenza vaccine correlates |
| Description | Home Privacy Policy Data protection Home About Flucop Project Description Governance Coordination team External advisory board K. Subbarao J. Van-Tam J. Weir J |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 35.214.186.170 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
flucop.eu Valuation
|
US$1,609,275
Last updated: 2023-05-15 17:55:59
flucop.eu has Semrush global rank of 6,577,064. flucop.eu has an estimated worth of US$ 1,609,275, based on its estimated Ads revenue. flucop.eu receives approximately 185,686 unique visitors each day. Its web server is located in United States, with IP address 35.214.186.170. According to SiteAdvisor, flucop.eu is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,609,275 |
| Daily Ads Revenue | US$1,486 |
| Monthly Ads Revenue | US$44,565 |
| Yearly Ads Revenue | US$534,775 |
| Daily Unique Visitors | 12,380 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| flucop.eu. | A | 86400 | IP: 35.214.186.170 |
| flucop.eu. | NS | 86400 | NS Record: ns1.siteground.net. |
| flucop.eu. | NS | 86400 | NS Record: ns2.siteground.net. |
| flucop.eu. | MX | 86400 | MX Record: 20 mx20.mailspamprotection.com. |
| flucop.eu. | MX | 86400 | MX Record: 30 mx30.mailspamprotection.com. |
| flucop.eu. | MX | 86400 | MX Record: 10 mx10.mailspamprotection.com. |
| flucop.eu. | TXT | 14400 | TXT Record: v=spf1 +a +mx +ip4:35.214.214.41 include:_spf.mailspamprotection.com ~all |
HtmlToTextCheckTime:2023-05-15 17:55:59
| Privacy Policy Data protection Home About Flucop Project Description Governance Coordination team External advisory board K. Subbarao J. Van-Tam J. Weir J. Wood Consortium Members News & Events Archived News & Events Publications Newsletters About IMI Contact Links Home Standardisation and development of assays for assessment of influenza vaccine correlates of protection The human influenza virus is the causative agent of one of the most important infectious diseases in the world, causing frequent (seasonal) epidemics as well as pandemics, both of which cause significant morbidity and mortality worldwide. Influenza virus infects all age groups but children and adults over the age of 65 are most at risk of severe morbidity and mortality. Vaccination is recommended for these age groups. Vaccination remains the most effective method to control seasonal infections and the most important strategy to prepare for a possible pandemic. Despite the development and licensure of influenza |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx Date: Fri, 07 Jan 2022 08:44:05 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive Location: https://flucop.eu/ Host-Header: 8441280b0c35cbc1147f8ba998a563a7 X-HTTPS-Enforce: 1 X-Proxy-Cache-Info: DT:1 |
flucop.eu Whois Information
Domain: flucop.eu Script: LATIN NOT DISCLOSED! Visit www.eurid.eu for webbased WHOIS. NOT DISCLOSED! Visit www.eurid.eu for webbased WHOIS. Name: Tucows.com Co. Website: http:///www.domainhelp.tucows.com/ ns2.siteground.net ns1.siteground.net Please visit www.eurid.eu for more info. |